Since our foundation in 2014 in Paris, we have been focused on creating solutions that leverage the power of machine learning to help clinicians better manage patients suffering from cardiac arrhythmia disorders.
Very soon afterwards, we partnered with leading cardiology experts to develop and validate our cutting-edge solution.
Our Cardiologs Holter Platform is the worlds’ first medical device powered by deep learning technology to have the CE mark, and amongst the first to receive FDA clearance.
